Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Releasing the mitochondrial respiration brake MCJ/DnaJC15 enhances CD8 CAR-T cell therapy efficacy
PubMed Full text in PMC Similar studies
Mitochondrial Arginase-2 deletion enhances the function of in vivo activated murine CD8+ T cells
PubMed Full text in PMC Similar studies SRA Run Selector
Anti-CD4 treatment affects TCR repertoire of CD8+ T cells
Anti-CD4 treatment increases tumor-suppressive IL18Rαhi CD8+ T cells
Anti-CD4 treatment-induced IL18Rαhi CD8+ T cells show highly effector profile
Gene expression data of CD8+ T cells from C57BL/6 mouse
PubMed Full text in PMC Similar studies Analyze with GEO2R
Nr4a transcription factors limit CAR-T cell function in solid tumors
Nr4a transcription factors limit CAR-T cell function in solid tumors [RNA-Seq]
Nr4a transcription factors limit CAR-T cell function in solid tumors [ATAC-Seq]
Cish inhibits CD8+ T cell immunity and disrupts proximal T cell receptor signaling
Expression data of ex vivo purified CD4+ cells from WT and P2rx7-/- mice
Genome-wide mapping of Cbx3/HP1g deposition in wild-type CD8+ effector T cells
Expression data for naïve IL-2 and IL-12 primed Pmel-1 CD8+ T-cells
CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [microarray]
CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [scRNA-seq]
CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy [ATAC-seq]
CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy.
CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. [RNA-Seq]
CRISPR screening reveals targets to reprogram long-lived effector CD8+ T cells for cancer therapy. [ATAC-Seq]
Rewiring the Mitochondrial Electron Transport Chain Enhances Tumor Immunogenicity
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on